143 related articles for article (PubMed ID: 9317091)
1. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
[No Abstract] [Full Text] [Related]
2. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Koh MT
Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
[No Abstract] [Full Text] [Related]
3. The genetic toxicity effects of lamivudine and stavudine antiretroviral agents.
Guimarães NN; de Andrade HH; Lehmann M; Dihl RR; Cunha KS
Expert Opin Drug Saf; 2010 Sep; 9(5):771-81. PubMed ID: 20377473
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir.
Villalba N; Gómez-Cano M; Casas E; Soriano V; Valencia E; González-Lahoz J
AIDS; 1997 Dec; 11(15):1896-7. PubMed ID: 9412717
[No Abstract] [Full Text] [Related]
6. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
Khouri S; Cushing H
AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
[TBL] [Abstract][Full Text] [Related]
7. Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV.
Yamamoto Y; Yasuoka A; Tachikawa N; Teruya K; Genka I; Yamaguchi M; Yasuoka C; Kikuchi Y; Aoki M; Oka S
Jpn J Infect Dis; 1999 Dec; 52(6):248-9. PubMed ID: 10738365
[No Abstract] [Full Text] [Related]
8. Negligence. Liver transplant patient too late to sue Viramune maker.
AIDS Policy Law; 2003 Mar; 18(6):7. PubMed ID: 12712930
[No Abstract] [Full Text] [Related]
9. FDA notifications. Tentative approval granted for lamivudine/stavudine.
AIDS Alert; 2008 Aug; 23(8):92-3. PubMed ID: 18727174
[No Abstract] [Full Text] [Related]
10. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
[TBL] [Abstract][Full Text] [Related]
11. Hepatic decompensation associated with lamivudine: a case report and review of lamivudine-induced hepatotoxicity.
Ormseth EJ; Holtzmuller KC; Goodman ZD; Colonna JO; Batty DS; Sjogren MH
Am J Gastroenterol; 2001 May; 96(5):1619-22. PubMed ID: 11374710
[TBL] [Abstract][Full Text] [Related]
12. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
Matthews GV; Cooper DA; Dore GJ
Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
[TBL] [Abstract][Full Text] [Related]
13. The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
Puoti M; Cozzi-Lepri A; Ancarani F; Bruno R; Ambu S; Ferraro T; Tundo P; Santantonio T; Toti M; Bonasso M; d'Arminio Monforte A; ;
Antivir Ther; 2004 Oct; 9(5):811-7. PubMed ID: 15535419
[TBL] [Abstract][Full Text] [Related]
14. Zidovudine + lamivudine: new preparation. Fewer tablets required.
Prescrire Int; 1999 Apr; 8(40):39-40. PubMed ID: 10848057
[TBL] [Abstract][Full Text] [Related]
15. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.
Andreone P; Gramenzi A; Cursaro C; Biselli M; Cammà C; Trevisani F; Bernardi M
J Viral Hepat; 2004 Sep; 11(5):439-42. PubMed ID: 15357649
[TBL] [Abstract][Full Text] [Related]
16. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
17. [HIV-HBV coinfection and the liver].
Aaron L; Carnot F; Pialoux G
Gastroenterol Clin Biol; 2001 May; 25(5):538-42. PubMed ID: 11521107
[No Abstract] [Full Text] [Related]
18. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
Murphy RL
Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.
Yao FY; Terrault NA; Freise C; Maslow L; Bass NM
Hepatology; 2001 Aug; 34(2):411-6. PubMed ID: 11481627
[TBL] [Abstract][Full Text] [Related]
20. Phase II/III Trials of Viracept start.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
